Volver a Agenda
Session 14: The Common Technical Document - An Overview Module 1-5
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Organization and Review of Module 1
¿Tiene una cuenta?